Connection
Paul Toren to Cytochrome P-450 CYP2C19
This is a "connection" page, showing publications Paul Toren has written about Cytochrome P-450 CYP2C19.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.081 |
|
|
|
-
Kyler KE, Gaedigk A, Abdel-Rahman S, Staggs VS, Pearce RE, Toren P, Leeder JS, Shakhnovich V. Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children. Clin Transl Sci. 2024 04; 17(4):e13782.
Score: 0.057
-
Ogilvie BW, Yerino P, Kazmi F, Buckley DB, Rostami-Hodjegan A, Paris BL, Toren P, Parkinson A. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug Metab Dispos. 2011 Nov; 39(11):2020-33.
Score: 0.024